U.S. Semiconductors Stock News

NasdaqGS:KMTS
NasdaqGS:KMTSMedical Equipment

Is Kestra Medical Technologies (KMTS) Overvalued After Its Recent Share Price Climb?

Kestra Medical Technologies (KMTS) has been quietly grinding higher, with the stock up around 2% on the day, nearly 9% over the past week, and roughly 24% year to date. See our latest analysis for Kestra Medical Technologies. That kind of steady climb in the share price, capped by a 1 day share price return of just under 2 percent, suggests momentum is building as investors warm to Kestra Medical Technologies growth story and reassess its risk profile. If this move in Kestra Medical...
NasdaqGM:IVVD
NasdaqGM:IVVDBiotechs

Exploring Three High Growth Tech Stocks In The US Market

Amidst a backdrop of declining major stock indexes, with the S&P 500 and Dow Jones Industrial Average experiencing their fourth consecutive losses due to AI bubble concerns and tepid labor data, the tech-heavy Nasdaq has also seen a recent decline. In this environment, identifying high-growth tech stocks requires careful consideration of companies that demonstrate resilience and potential for innovation despite broader market challenges.
NYSE:BBT
NYSE:BBTBanks

December 2025's Top Stocks Estimated Below Intrinsic Value

As December 2025 unfolds, the U.S. stock market faces a challenging period with major indices like the S&P 500 and Dow Jones Industrial Average experiencing consecutive declines amid AI bubble concerns and rising unemployment rates. In such an environment, identifying undervalued stocks becomes crucial for investors seeking opportunities that may offer potential value relative to their intrinsic worth.
NasdaqGS:CSIQ
NasdaqGS:CSIQSemiconductor

3 Growth Companies With High Insider Ownership And 13% Revenue Growth

As the U.S. stock market experiences a pullback with major indices like the S&P 500 and Dow Jones facing consecutive losses, investors are increasingly cautious amid concerns over an AI bubble and tepid labor data. In such uncertain times, growth companies with high insider ownership can offer a compelling option as they often align management's interests with those of shareholders, potentially leading to sustained revenue growth despite broader market challenges.
NasdaqCM:NNDM
NasdaqCM:NNDMMachinery

Nano Dimension And 2 Other Penny Stocks With Promising Potential

As the U.S. stock market experiences a pullback, with major indices like the Dow Jones and S&P 500 facing consecutive losses amid tech sector concerns, investors are increasingly looking for opportunities outside the mainstream. Penny stocks, though often overlooked, continue to present intriguing possibilities for those willing to explore smaller or newer companies that could offer unique growth potential. In this article, we will examine three penny stocks that stand out due to their...
NasdaqGS:TSAT
NasdaqGS:TSATTelecom

Telesat (NasdaqGS:TSAT): Rethinking Valuation After a Strong Multi‑Year Share Price Rally

Telesat (NasdaqGS:TSAT) has quietly turned into a strong performer, with the stock up around 73% this year and roughly 60% over the past year, even as earnings remain in the red. See our latest analysis for Telesat. At a share price of $29.11, Telesat’s 16.95% 30 day share price return and 3 year total shareholder return of 358.43% suggest investors are steadily repricing its long term potential despite recent volatility. If Telesat’s surge has you rethinking what could move next, this might...
NasdaqGS:MIST
NasdaqGS:MISTPharmaceuticals

Milestone Pharmaceuticals (MIST) Is Down 16.3% After First-in-Decades At-Home PSVT Drug Approval - Has The Bull Case Changed?

Milestone Pharmaceuticals recently received U.S. Food and Drug Administration approval for CARDAMYST (etripamil) nasal spray, its first commercial product for at-home conversion of acute symptomatic paroxysmal supraventricular tachycardia (PSVT) to sinus rhythm in adults, with retail availability targeted for early 2026. This is the first new FDA-approved PSVT treatment in over 30 years and introduces a self-administered, out-of-hospital option for more than two million affected Americans,...
NasdaqGM:VERI
NasdaqGM:VERISoftware

Can Veritone’s (VERI) New Public-Sector AI Deals Deepen Its Justice and Safety Moat?

In early December 2025, Veritone, Inc. announced new public-sector collaborations and deployments, including integrating its iDEMS suite into Strategic Communications’ JPS TRUST program and partnering with Armada to deliver an edge-to-enterprise AI data fabric running on private AWS and Azure environments. These moves deepen Veritone’s role in AI-driven digital evidence and unstructured data management, potentially widening its reach across justice, public safety, federal, and commercial...
NasdaqGS:ALRM
NasdaqGS:ALRMSoftware

Alarm.com (ALRM): Valuation Check After New Video Intercom Launch and Everon Commercial Alliance

Alarm.com (ALRM) just rolled out a low cost Video Intercom Mobile Directory and expanded its commercial footprint through a new Everon alliance, developments that quietly strengthen the stock’s long term smart security narrative. See our latest analysis for Alarm.com Holdings. Despite these product and partnership wins, Alarm.com Holdings’ share price has drifted lower this year, with a negative year to date share price return and a weak one year total shareholder return. This suggests...
NasdaqGS:BWIN
NasdaqGS:BWINInsurance

Insider Sale and New Debt Capacity Could Be A Game Changer For Baldwin Insurance Group (BWIN)

Earlier in December 2025, Baldwin Insurance Group President James Morgan Roche sold 239,200 Class A shares for about US$5.74 million, while the company reported third-quarter earnings that exceeded analyst expectations and secured lender commitments for a US$600 million incremental term loan, lifting its facility to US$1.60 billion. This combination of insider selling, stronger-than-forecast financial results, and expanded borrowing capacity has sharpened investor focus on Baldwin’s growth...
NYSE:REX
NYSE:REXOil and Gas

REX American Resources (REX): Reassessing Valuation After Stable Q3 Results and Softer Year-to-Date Profits

REX American Resources (REX) just posted its third quarter numbers, showing sales essentially flat year over year while earnings per share inched higher, even as year to date net income drifted lower. See our latest analysis for REX American Resources. That steadiness in the latest earnings comes after a strong run, with the share price up about 55% year to date and a 1 year total shareholder return of nearly 61%. This suggests positive momentum despite recent profit pressure. If REX's move...
NasdaqGS:PGEN
NasdaqGS:PGENBiotechs

US High Growth Tech Stocks To Watch December 2025

As the United States market navigates a period of volatility, with major indexes closing lower amid concerns over an AI bubble and looming economic reports, investors are keenly observing the tech sector's dynamics. In such a climate, identifying high-growth tech stocks involves looking for companies with strong fundamentals and resilience to market pressures.
NasdaqGS:NTNX
NasdaqGS:NTNXSoftware

3 Stocks Estimated To Be Trading At Discounts Of 23.8% To 35.3%

As the United States stock market grapples with concerns over an AI bubble and fluctuating major indexes, investors are keenly observing economic indicators like the upcoming jobs report to gauge future market directions. In this environment of uncertainty, identifying stocks that are potentially undervalued can offer opportunities for those looking to capitalize on price discrepancies; such stocks may be trading at significant discounts relative to their intrinsic value, providing a...
NasdaqCM:PAYS
NasdaqCM:PAYSDiversified Financial

Three Insider-Favored Growth Companies To Watch

As the U.S. stock market grapples with pressures on AI stocks and anticipates key economic data releases, investors are keenly observing how these factors influence broader market trends. In such a volatile environment, growth companies with high insider ownership often stand out as they suggest confidence from those closest to the business, making them intriguing prospects for investors seeking stability amid uncertainty.